Small molecular compounds that inhibit hepatitis C virus replication through destabilizing heat shock cognate 70 messenger RNA

New Therapies for Hepatitis C Virus Infection

(2009) Vincent Soriano et al.   CLINICAL INFECTIOUS DISEASES

The heat shock cognate protein 70 is associated with hepatitis C virus particles and modulates virus infectivity

(2009) Romain Parent et al.   HEPATOLOGY

Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients

(2009) Simone Susser et al.   HEPATOLOGY

Antiviral resistance and specifically targeted therapy for HCV (STAT-C)

(2009) A. J. V. Thompson et al.   JOURNAL OF VIRAL HEPATITIS

New and experimental therapies for HCV

(2009) Arema A. Pereira et al.   Nature Reviews Gastroenterology & Hepatology

Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection

(2009) Christophe Hézode et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection

(2009) John G. McHutchison et al.   NEW ENGLAND JOURNAL OF MEDICINE

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

(2009) John G. McHutchison et al.   NEW ENGLAND JOURNAL OF MEDICINE

Identification of HCV protease inhibitor resistance mutations by selection pressure-based method

(2009) P. Qiu et al.   NUCLEIC ACIDS RESEARCH

Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients

(2008) Thomas Kuntzen et al.   HEPATOLOGY

Hepatitis C therapies

(2008) Irena Melnikova   NATURE REVIEWS DRUG DISCOVERY

Interferon-based therapy for chronic hepatitis C: current and future perspectives

(2008) Stefan Zeuzem   Nature clinical practice. Gastroenterology & hepatology